OrbiMed’s Xilio Therapeutics XLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.36M Hold
592,300
– – 0.1% 93
2026
Q2
$5.67M Buy
+592,300
New +$4.95M 0.11% 99

Other funds holding XLO

OrbiMed's XLO Position: Q3 2026 in Review

OrbiMed held its Xilio Therapeutics (XLO) position steady in Q3 2026 at 592,300 shares worth $5.36M. The position accounts for 0.1% of the portfolio, ranked #93.

OrbiMed first reported a position in XLO in Q2 2026 and has held it in 2 quarters since. The position peaked at $5.67M in Q2 2026. 30 funds tracked by Wall St. Rank hold XLO as of Q3 2026.

  • OrbiMed held 592,300 shares of Xilio Therapeutics worth $5.36M as of Q3 2026.
  • OrbiMed left its Xilio Therapeutics share count unchanged in Q3 2026.
  • Xilio Therapeutics made up 0.1% of OrbiMed's portfolio in Q3 2026, its #93 holding.
  • OrbiMed first reported a position in Xilio Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • OrbiMed's Xilio Therapeutics position peaked at $5.67M in Q2 2026.
  • 30 funds tracked by Wall St. Rank held Xilio Therapeutics as of Q3 2026.

Based on OrbiMed's 13F filing for Q3 2026, filed 16 Nov 2026.